Julius Wanjau

Designed and characterised nanoemulsion and nanoemulgel formulations for topical skin cancer therapy, using HPLC and UV-Vis to evaluate stability, droplet size, and entrapment efficiency and presenting results at an international conference.

Processed 60+ prescriptions daily with zero dispensing errors, managed inventory worth ₹100,000+, and conducted BP and glucose screenings for 200+ patients with counselling and referrals.

Executed CRISPR/Cas9 genome editing experiments and analysed multiple gene sequences, meeting 100% of project objectives and co-authoring a supervisor-commended research report with IIT Hyderabad collaborators.

Delivered health literacy and mental well-being workshops to multiple communities and facilitated educational programs for 50+ children to improve grassroots health awareness.

Reported 15+ adverse drug reactions through pharmacovigilance channels, counselled 100+ patients on adherence and interactions, and dispensed 80–100 prescriptions weekly in compliance with safety standards.

Grade: First Class with Distinction (CGPA 8.70/10)

Activities and societies: Undergraduate research in nanoemulsions and nanoemulgels (presented at international conference); participation in molecular docking workshop and pharmacovigilance activities.

Completed a Bachelor of Pharmacy with first-class distinction and a focus on nanotechnology, drug delivery systems, and molecular biology; thesis work produced two conference posters on nanoemulsion and nanoemulgel topical therapies.